You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)
Recruiting
  • Lymphoma, T-cell, Peripheral
  • Lymphoma, T-cell, Cutaneous
  • Nagoya, Japan
  • +2 more
2021-11-16
Nov 16, 2021
P
Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas - 2018
Terminated
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides
  • Bydgoszcz, Poland
    Centrum Onkologii im. prof. F. Łukaszczyka
2021-12-23
Dec 23, 2021
N
Characterization of the Microbiome in Cutaneous T Cell Lymphoma
Recruiting
  • Cutaneous T Cell Lymphoma
    • Chicago, Illinois
      Northwestern University
    2021-10-02
    Oct 2, 2021
    M
    Diagnostic Classifier for Cutaneous T-cell Lymphomas
    Recruiting
    • CTCL/ Mycosis Fungoides
    • Skin suction blistering and skin biopsies
    • Vienna, Austria
      Medical University of Vienna
    2022-04-04
    Apr 4, 2022
    S
    Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
    Active, not recruiting
    • Mycoses
    • +5 more
    • anti-thymocyte globulin
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    2021-07-29
    Jul 29, 2021
    C
    Tissue Repository: CTCL Collection Protocol
    Recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +2 more
      • New York, New York
        Columbia University Medical Center
      2021-03-10
      Mar 10, 2021
      I
      Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides
      Recruiting
      • Lymphoma, T-Cell, Cutaneous
      • Mycosis Fungoides
      • single-arm, non-randomized Biodynamic imaging (BDI)
      • Indianapolis, Indiana
        Indiana University School of Medicine, Department of Dermatology
      2021-11-17
      Nov 17, 2021
      F
      A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma
      Recruiting
      • Cutaneous T-cell Lymphoma (CTCL)
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      2022-02-02
      Feb 2, 2022
      D
      A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
      Recruiting
      • Cutaneous T Cell Lymphoma
      • Peripheral T Cell Lymphoma
      • Microdevices
      • +2 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      2021-06-22
      Jun 22, 2021
      U
      Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
      Recruiting
      • Cutaneous T-cell Lymphoma
      • +4 more
      • Blood draw, skin biopsy or urine collection
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Medical Center
      2021-11-16
      Nov 16, 2021
      F
      AEDV Registry of Primary Cutaneous Lymphoma
      Recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +5 more
      • Registry of patients (exposure is Cutaneous Lymphoma)
      • Barcelona, Spain
      • +13 more
      2022-03-15
      Mar 15, 2022
      C
      Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.
      Not yet recruiting
      • Mycosis Fungoides of Skin (Diagnosis)
      • +5 more
      • Med-Jet Injector
      • +4 more
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      2022-01-24
      Jan 24, 2022
      K
      Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
      Recruiting
      • Non Hodgkin Lymphoma (NHL)
      • +4 more
      • Cincinnati, Ohio
        The Christ Hospital Cancer Center
      2022-02-08
      Feb 8, 2022
      E
      Study of Photopheresis in the Treatment of Erythrodermic MF and SS
      Withdrawn
      • Lymphoma, T-Cell, Cutaneous
      • Mycosis Fungoides/Sezary Syndrome
      • Zürich, Switzerland
        UniversitaetsSpital Zurich - Division of Dermatology
      2021-08-31
      Aug 31, 2021
      F
      Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)
      Recruiting
      • Cutaneous T Cell Lymphoma
      • Micro needle array-Doxorubicin (MNA-D)
      • Pittsburgh, Pennsylvania
        University Of Pittsburgh Medical Center
      2021-11-11
      Nov 11, 2021
      L
      Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
      Active, not recruiting
      • T-Cell Lymphoma
      • +4 more
      • LB1901
      • Rochester, Minnesota
      • +3 more
      2022-02-15
      Feb 15, 2022
      D
      Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
      Active, not recruiting
      • Cutaneous T Cell Lymphoma
      • Graft Versus Host Disease
        • Lebanon, New Hampshire
          Dartmouth-Hitchcock Medical Center
        2021-08-31
        Aug 31, 2021
        R
        Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma - 2021
        Terminated
        • Cutaneous T-cell Lymphoma
        • +2 more
        • Doxycycline monohydrate
        • Rochester, New York
          Rochester General Hospital
        2021-04-23
        Apr 23, 2021
        C
        A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma - 2012
        Terminated
        • Cutaneous T-cell Lymphoma (CTCL)
        • Stanford, California
        • +2 more
        2021-12-07
        Dec 7, 2021
        Y
        A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) - 2021
        Completed
        • CTCL
        • ABT-199 (venetoclax)
        • New Haven, Connecticut
          Yale New Haven Hospital / Smilow Cancer Center
        2021-06-22
        Jun 22, 2021
        N
        Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
        Recruiting
        • Cutaneous T-Cell Lymphoma
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2022-04-07
        Apr 7, 2022
        P
        Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma
        Recruiting
        • Lymphoma, T-Cell, Cutaneous
        • +2 more
        • Lenalidomide 15mg
        • Brentuximab Vedotin 1.8 mg/Kg
        • Melbourne, Victoria, Australia
          Peter MacCallum Cancer Centre
        2020-09-29
        Sep 29, 2020
        S
        Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
        Not yet recruiting
        • T-cell Lymphoma
        • +10 more
        • Chicago, Illinois
          Rush University Medical Center
        2021-09-20
        Sep 20, 2021
        S
        Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease
        Recruiting
        • Cutaneous T-Cell Lymphoma, Unspecified
        • Chronic Graft Versus Host Disease in Skin
        • ECP with 5-aminolevulinic acid
        • Trondheim, Norway
          St Olavs Hospital
        2021-10-29
        Oct 29, 2021
        K
        Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001 - 2012
        Completed
        Has Results
        • Peripheral T-cell Lymphoma
        • Cutaneous T-cell Lymphoma
        • KW-0761
        • Stanford, California
          Stanford University
        2020-12-03
        Dec 3, 2020